Press Releases

PANGYO, South Korea and PARAMUS, N.J., Nov. 21, 2019 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., an innovative global pharmaceutical company focused on deve

DALLAS, Nov. 21, 2019 /PRNewswire/ -- The Hopemore, the first specialty spa in the Metroplex to specialize in everyday esthetics as well as services for those experiencing injury, illness or elective procedures, has opened in the sixth-floor salon area of Neiman Marcus' Downtown Dallas flagship store.

TUCSON, Ariz., Nov. 21, 2019 /PRNewswire/ -- On Nov 20, the fifth debate by Democrat Presidential hopefuls devoted considerable attention to "climate change"—that is, predicted catastrophic climate disruptions caused by human emissions of greenhouse gases, especially carbon dioxide.

NEW YORK, Nov. 21, 2019 /PRNewswire/ -- The 2019 Annual Achilles International Gala, named The Courage to Go Forward, raised more than $1.7 million in a single evening, making it the largest fundraising event in the organization's history. Achilles International is dedicated to helping people with disabi

HOUSTON, Nov. 21, 2019 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("Company"), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced the closing of the issuance of an additional 318,750 shares of its common stock pursuant to the exercise in full of the underwriters' over-allotment option in connec

SILVER SPRING, Md., Nov. 21, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved XCOPRI (cenobamate tablets) to treat partial-onset seizures in adults.

DURHAM, N.C., Nov. 21, 2019 /PRNewswire/ -- TARGET PharmaSolutions' TARGET-IBD poster "Medication Use and Comorbidities Among Elderly as Compared to Younger Patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort" was designated a Presidential Poster at the American College of Gastroenterology (ACG) Annual Scientific Meeting in San Antonio, Texas.

VAUGHAN, ON, Nov. 21, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) today is providing a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"), which require the Company to provide bi-weekly upda

ST. LOUIS, Nov. 21, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene" or the "Company") announced today that it has priced its offering of $7,000,000,000 aggregate principal amount of senior notes. The $7,000,000,000 of senior notes will include $1,000,000,000

MILAN and MALIBU, Calif., Nov. 21, 2019 /PRNewswire/ -- Progenabiome's Jordan Daniels is slated to present a Case Study of metastatic mesothelioma treated with Fecal Microbiota Transplant (FMT) as adjunctive therapy to Pembrolizumab.